Cyclic olefin homopolymer-based microfluidics for protein crystallization and in situ X-ray diffraction by Emamzadah, Soheila et al.
research papers
Acta Cryst. (2009). D65, 913–920 doi:10.1107/S0907444909021489 913
Acta Crystallographica Section D
Biological
Crystallography
ISSN 0907-4449
Cyclic olefin homopolymer-based microfluidics for
protein crystallization and in situ X-ray diffraction
Soheila Emamzadah,
a,b‡ Tom J.
Petty,
a,c‡ Victor De Almeida,
a,b
Taisuke Nishimura,
d Jacques
Joly,
e Jean-Luc Ferrer
e and
Thanos D. Halazonetis
a,b*
aDepartment of Molecular Biology, University of
Geneva, CH-1205 Geneva, Switzerland,
bDepartment of Biochemistry, University of
Geneva, CH-1205 Geneva, Switzerland,
cBiomedical Graduate Studies Genomics and
Computational Biology Group, University of
Pennsylvania, Philadelphia, PA 19104, USA,
dDepartment of Plant Biology, University of
Geneva, CH-1205 Geneva, Switzerland, and
eInstitut de Biologie Structurale J.-P. Ebel,
CEA–CNRS–University J. Fourier,
38027 Grenoble CEDEX 1, France
‡ These authors contributed equally to this
work.
Correspondence e-mail:
thanos.halazonetis@unige.ch
Microﬂuidics is a promising technology for the rapid iden-
tiﬁcation of protein crystallization conditions. However, most
of the existing systems utilize silicone elastomers as the chip
material which, despite its many beneﬁts, is highly permeable
to water vapour. This limits the time available for protein
crystallization to less than a week. Here, the use of a cyclic
oleﬁn homopolymer-based microﬂuidics system for protein
crystallization and in situ X-ray diffraction is described. Liquid
handling in this system is performed in 2 mm thin transparent
cards which contain 500 chambers, each with a volume of
320 nl. Microbatch, vapour-diffusion and free-interface diffu-
sion protocols for protein crystallization were implemented
and crystals were obtained of a number of proteins, including
chicken lysozyme, bovine trypsin, a human p53 protein
containing both the DNA-binding and oligomerization
domains bound to DNA and a functionally important domain
of Arabidopsis Morpheus’ molecule 1 (MOM1). The latter two
polypeptides have not been crystallized previously. For X-ray
diffraction analysis, either the cards were opened to allow
mounting of the crystals on loops or the crystals were exposed
to X-rays in situ. For lysozyme, an entire X-ray diffraction data
set at 1.5 A ˚ resolution was collected without removing the
crystal from the card. Thus, cyclic oleﬁn homopolymer-based
microﬂuidics systems have the potential to further automate
protein crystallization and structural genomics efforts.
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1. Introduction
Crystallization of proteins and determination of their three-
dimensional structure provides biological information that is
often critical to understanding their function. Indeed, it has
been proposed that the three-dimensional structures of all
proteins should be solved and the term ‘structural genomics’
has been used for these efforts. So far, these efforts have met
with mixed success (Service, 2002; Chandonia & Brenner,
2006), in part because protein crystallization is a tedious and
time-consuming process that is not easily amenable to auto-
mation. Nevertheless, progress towards automation has been
made and currently many crystallographers rely on some level
of automation for their daily experiments.
Perhaps the most widely used systems for automating pro-
tein crystallization are pipetting/robotic systems that simply
recapitulate the steps performed by humans (Hui & Edwards,
2003). One set of pipetting systems prepares crystallization
reactions by mixing a precipitant solution with the protein to
be crystallized in very small drops (about 200 nl in volume).
These drops are placed in chambers containing a much larger
volume of precipitant solution. Through vapour diffusion, the
volume of the protein drop slowly decreases, leading to pro-
tein crystallization. This type of pipetting system has gainedacceptance because vapour diffusion is a well established
method of protein crystallization (Hui & Edwards, 2003;
Chayen & Saridakis, 2008) and because it utilizes about ten
times less protein than would be required if the same reactions
were set up manually. However, a disadvantage of pipetting
systems is that the small volume of the protein–precipitant
drops leads to signiﬁcant water evaporation before the
chambers are sealed. The degree of evaporation can vary from
drop to drop, creating heterogeneity in the experiment, and
even occurs when the reactions are prepared in a humidiﬁed
environment. Robotic systems have also been developed to
identify crystals in protein–precipitant drops; these systems
consist of a cabinet, in which crystallization plates are stored, a
robotic arm and a microscope (Hui & Edwards, 2003). Several
images are acquired from each drop (at various focal planes,
since the drops are not ﬂat) and these images are then pro-
cessed by software that attempts to identify protein crystals,
which is a difﬁcult task because the drop geometry leads to
poor images. Finally, a robotic system has also been developed
to position crystallization trays in the path of a synchrotron
X-ray beam (Jacquamet et al., 2004). This system can screen
crystals for their ability to diffract X-rays and allows some
crystal parameters, such as space group and unit-cell size, to be
determined without manual handling of the crystals.
As an alternative to the systems described above, efforts
have been made to use microﬂuidics for protein crystal-
lization. Several such systems have been developed, most of
them employing chips made of elastic silicone (Hansen &
Quake, 2003). In one system, the chips contain wells that are
connected by a channel; the elastomeric nature of the chips
permits the channel to be sealed by applying mechanical
pressure to the chip (Hansen et al., 2002, 2004, 2006). In its
most simple form, two wells are ﬁlled with protein and
precipitant solution, respectively; the pressure on the channel
connecting these two wells is then released, allowing the
contents of the wells to mix by a process called free-interface
diffusion. Depending on the viscocity of the liquids, equili-
bration of the contents of the two connected chambers is
achieved in as little as 1 h. Crystal growth is followed over a
period of a few days, but generally for less than a week. The
observation time is limited by evaporation of water through
the silicone, which is intrinsic to the nature of these micro-
ﬂuidic chips because the silicone elastomer is permeable
to water vapour. On the other hand, water evaporation
also offers the advantage that it results in higher protein–
precipitant concentrations, which may favour crystallization.
Another microﬂuidics system mixes protein and precipitant
in nanolitre-volume droplets which are formed within water-
immiscible ﬂuids ﬂowing inside capillary channels (Zheng et
al., 2003, 2004; Li et al., 2006). The droplets initially form in
silicone elastomer channels, but are eventually guided into
glass or Teﬂon capillary tubes, which are then sealed to
prevent evaporation. Depending on the nature of the ﬂuid
separating the droplets, this system crystallizes proteins by
microbatch or vapour-diffusion methods. When the oil separ-
ating the droplets is impermeable to water, the proteins
crystallize by the microbatch method. For vapour diffusion,
protein–precipitant droplets alternate with droplets containing
high concentrations of salt and are separated by a water-
permeable oil; this allows the slow transfer of water from the
protein–precipitant droplets to the high-salt droplets, resulting
in a vapour-diffusion effect.
The use of silicone elastomer is prevalent in microﬂuidics
systems and offers certain advantages, as described above.
However, the water-vapour permeability of silicone limits its
use in cases where protein crystallization requires incubation
with precipitant for more than a few days. Thus, microﬂuidics
systems that utilize vapour-impermeable chips could provide
an alternative to silicone elastomer-based systems. Here, we
describe our experience with a microﬂuidics system that uses
cyclic oleﬁn homopolymer (COP) as the chip material. We
demonstrate the crystallization of several proteins at 277 K
and at room temperature using microbatch, vapour-diffusion
and free-interface diffusion protocols.
2. Experimental procedures
2.1. Protein-sample preparation
Chicken egg-white lysozyme (gene accession code NM_
205281) and bovine pancreatic trypsin (gene accession code
NM_001113727) were purchased as lyophilized powders from
Sigma–Aldrich (St Louis, Missouri, USA) and AppliChem
(Darmstadt, Germany), respectively. Lysozyme (140 mg ml
 1)
was resuspended in 50 mM sodium acetate pH 4.5, whereas
trypsin (80 mg ml
 1) was resuspended in 25 mM HEPES pH
7.0, 10 mM calcium chloride, 10 mg ml
 1 benzamidine hydro-
chloride.A polypeptideconsistingofresidues94–291ofhuman
p53 (gene accession code NM_000546) fused to residues 322–
356 was expressed in Escherichia coli. The cells were lysed in a
buffer consisting of 25 mM bis-tris propane (BTP) pH 6.8,
250 mM NaCl, 5 mM DTT and protease inhibitors and the
polypeptide was puriﬁed by cation exchange (Sepharose SP
column; Pharmacia Biotech, Uppsala, Sweden) and gel ﬁltra-
tion (Superdex 200 column; Pharmacia Biotech). After puri-
ﬁcation, the p53 protein was concentrated to 8 mg ml
 1 in
25 mM bis-tris propane pH 6.8, 50 mM NaCl, 5 mM DTT
buffer. A polypeptide corresponding to amino acids 1699–
1814 of Arabidopsis thaliana Morpheus’ molecule 1 (MOM1;
geneaccessioncode NM_179277)was alsoexpressed inE.coli.
The cells were lysed in buffer consisting of 25 mM MES pH
6.0, 200 mM NaCl, 5 mM DTT and protease inhibitors; the
polypeptide was then puriﬁed by cation exchange (Sepharose
SP column; Pharmacia Biotech) and gel ﬁltration (Superdex
200 column; Pharmacia Biotech) and concentrated to
6m gm l
 1 in lysis buffer.
2.2. Protein crystallization
Proteins were crystallized either under standard hanging-
drop vapour-diffusion conditions in 48-well plates (Hampton
Research, Aliso Viejo, California, USA) or in COP cards using
a dedicated microﬂuidics instrument (SpinX Technologies,
Meyrin, Switzerland). Lysozyme and trypsin were crystallized
at room temperature and the MOM1 fragment was crystal-
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double-stranded DNA containing a high-afﬁnity p53 DNA-
binding site at 277 K at a 1:1.1 protein:DNA molar ratio.
The double-stranded DNA was prepared by annealing the
following two oligonucleotides: 50-AGAC GGG CATG TCT
GGG CATG TCT CA-30 and 50-CTTG AGA CATG CCC
AGA CATG CCC GT-30. The precipitant solutions used for
crystallization were as follows: 4–30%(w/v) PME 5000, 1 M
sodium chloride, 50 mM sodium acetate pH 4.5 for lysozyme;
30%(w/v) PEG 8000, 0.2 M ammonium sulfate, 0.1 M sodium
cacodylate pH 6.5 for trypsin; Index Screen No. 87 [20%(w/v)
PEG 3350, 0.2 M sodium malonate pH 7.0], Index Screen No.
89 [15%(w/v) PEG 3350, 0.1 M succinic acid pH 7.0] and Index
Screen No. 90 [20%(w/v) PEG 3350, 0.2 M sodium formate
pH 7.0] for p53–DNA complexes and 0.2–0.4 M magnesium
formate, 0.1 M Tris pH 8.5 for MOM1. All crystallization
buffers and precipitants were purchased from Hampton
Research.
2.3. Data collection and processing
All data sets were collected on the FIP-BM30A beamline of
the ESRF (Grenoble, France; Roth et al., 2002). For in situ
data collection, COP cards containing lysozyme crystals were
positioned in the path of the X-ray beam using a robotic arm,
as described previously (Jacquamet et al., 2004). Reﬂection
data were indexed, integrated and scaled using the program
XDS (Kabsch, 1993). The crystals formed in space group
P43212, with unit-cell parameters a =7 7 . 1 ,b= 77.1, c= 37.2 A ˚ ,
and contained one molecule in the asymmetric unit. The
coordinates of lysozyme (PDB code 1iee) were used as input
for reﬁnement, which was performed with the program CNS
(Bru ¨nger et al., 1998). The electron-density maps and the
protein atoms were visualized using the program O (Jones et
al., 1991).
3. Results
3.1. Principle of operation of a cyclic olefin homopolymer-
based microfluidics device
Most microﬂuidics devices use either silicone elastomers or
rigid COPs as the chip material. The vapour-permeability of
COPs is several orders of magnitude lower than that of sili-
cone (Mair et al., 2006), which in theory should make COPs
better suited for traditional methods of protein crystallization,
where no vapour exchange of the crystallization chamber with
the outside environment is desirable (Chayen & Saridakis,
2008). To explore the potential of COPs in protein crystal-
lization, we used a microﬂuidics instrument in which the
movement and mixing of liquids in COP chips is controlled by
centrifugal forces (SpinX Technologies). In this particular
system, the microﬂuidics chip takes the form of a card made of
two COP pieces bonded together via a thin COP membrane
(Figs. 1a and 1b). One side of the COP card has chambers
arranged in rows and horizontal channels. The chambers have
dimensions of 2   0.7   0.25 mm, corresponding to a volume
of about 320 nl. The other side of the COP card contains
vertical channels. Connections between chambers and vertical
channels, and between vertical and horizontal channels are
made by a laser that opens holes in the thin membrane that
separates the two sides of the card. Depending on where the
openings are made, speciﬁed volumes of liquid can be directed
from a chamber in one row to a chamber in the row ‘below’
(Fig. 1b). The movement of the liquids is driven by the
centrifugal force generated as the cards are spinning in the
instrument.
3.2. Establishment of microbatch, vapour-diffusion and free-
interface diffusion crystallization protocols
The COP cards used in this study permit the establishment
of several protocols for protein crystallization. In the tradi-
tional microbatch protocol, protein and precipitant solutions
are mixed and the resulting aqueous solution is overlaid with
low-density parafﬁn oil, which is impermeable to water vapour
(Chayen & Saridakis, 2008). This protocol can easily be
established in the COP cards simply by directing appropriate
volumes of protein and precipitant solutions to the same
chamber. Even though the holes that are opened to direct the
liquids in the chambers are never sealed, the very small cross-
sectional area of the channels results in very small evaporation
rates; even after several months the volume of liquid in the
chambers does not change appreciably (data not shown).
The second protocol that we established in the COP cards
was vapour diffusion (Chayen & Saridakis, 2008). Protein and
precipitant solutions were mixed in one chamber, while an
adjacent chamber was ﬁlled with precipitant solution only.
Connections were then established between these two cham-
bers by opening holes above the liquid level (Fig. 1c). When
the COP cards were incubated at room temperature, changes
in the volumes of the liquids in the two chambers consistent
with vapour diffusion were observed within 6 d (Fig. 1d).
However, at 277 K vapour diffusion proceeded more slowly, as
would be expected.
The third protocol established in the COP cards was free-
interface diffusion (Chayen & Saridakis, 2008). One chamber
was ﬁlled with protein solution, while an adjacent chamber
was ﬁlled with precipitant solution. Connections between
these two chambers were again established, but in this case by
opening holes below the liquid level (Fig. 1e). For both the
vapour-diffusion and free-interface diffusion protocols, the
rate of diffusion can be controlled by opening a larger or
smaller number of connections between the chambers
(between one and ﬁve for vapour diffusion and between one
and three for free-interface diffusion).
3.3. Protein crystallization in COP cards
The suitability of new protein crystallization platforms is
usually documented in the literature using proteins that
crystallize readily. Following this tradition, we used the
microbatch method to monitor the crystallization of chicken
egg-white lysozyme and bovine pancreatic trypsin in the COP
cards. For both proteins crystallization was performed in ﬁnal
volumes of 200 nl at room temperature. For lysozyme we
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from 20 to 60 mg ml
 1 and PME 5000 concentrations ranging
from 4 to 30%. Crystals formed at protein concentrations of
between 22 and 30 mg ml
 1 and at PME concentrations of
between 18 and 30% (Fig. 2a). For tryspin, the ﬁnal protein
concentrations ranged from 15 to 40 mg ml
 1 and PEG 8000
was used at a concentration of 30%. Crystals formed at pro-
tein concentrations of between 25 and 30 mg ml
 1 (Fig. 2a).
Lysozyme and trypsin also crystallized in the COP cards using
the vapour-diffusion and free-interface diffusion protocols
(Fig. 1d and data not shown).
Because lysozyme and trypsin crystallize readily, we then
studied other proteins that might be more difﬁcult to crys-
tallize. We ﬁrst focused on the human p53 tumour-suppressor
protein. The gene encoding p53 is the most frequently mutated
gene in human cancer (Hollstein et al., 1991). The p53 protein
contains a transactivation domain, a sequence-speciﬁc DNA-
binding domain (residues 94–289) and a homotetramerization
domain (residues 325–356). The latter two domains are in-
dependently folding domains and their three-dimensional
structures have been determined (Cho et al., 1994; Jeffrey et
al., 1995); however, no structure is available of a p53 poly-
peptide containing both of these domains. Polypeptides con-
taining more than one independently folding domains are
generally not easy to crystallize, as the linker between the
domains imparts conformational ﬂexibility, which inhibits
crystallization. We engineered a p53 polypeptide containing
residues 94–291 of human p53 fused to residues 322–356.
Based on the boundaries of the crystallized DNA-binding and
tetramerization domains, this polypeptide has a ﬂexible
research papers
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Figure 1
Establishment of protein crystallization protocols in COP microﬂuidics cards. (a) Image of a microﬂuidics card. Samples are loaded at the top and then
move through the card by centrifugal force. (b) Diagram of a cross section of a COP card illustrating how deﬁned volumes of liquid are ‘pipetted’. Liquid
is contained within a chamber by the thin membrane separating the chambers from the vertical channels (1), holes are opened in the thin membrane by a
laser (yellow arrowheads; 2) and the liquid above the hole moves through the vertical channel to a chamber ‘below’ (3). The volume transferred is
determined by the vertical position of the hole in the thin membrane. (c) Vapour-diffusion protocol. Equal volumes of protein and precipitant were
dispensed into one chamber and precipitant only was dispensed into an adjacent chamber. Holes were then opened in the thin membrane above the
liquid level to establish connections between the chambers, according to the paths shown by the red lines. (d) Changes in liquid volume consistent with
vapour diffusion after 6 d of incubation of the COP card at room temperature. The level of liquid at day 0 is indicated by the red lines. The level of liquid
in the ‘precipitant’ chamber increases, while the level of liquid in the ‘protein–precipitant’ chamber decreases. In this example, the protein was lysozyme
and the black arrow indicates a crystal that formed within 6 d. (e) Free-interface diffusion protocol. Protein and precipitant were dispensed into two
adjacent chambers. Holes were then opened in the thin membrane below the liquid level to establish connections between the chambers, according to the
paths shown by the red lines. All images of individual chambers were acquired using the camera built into the microﬂuidics instrument. Images showing
multiple chambers were assembled from images acquired using an inverted microscope and a low-magniﬁcation lens (Zeiss, Gottingen, Germany).interdomain linker that is ﬁve amino acids long. Two amino-
acid substitutions were introduced in the tetramerization
domain of this polypeptide to convert it into a dimerization
domain (Davison et al., 2001). In addition, 13 amino-acid
substitutions were introduced in the DNA-binding domain in
order to increase its melting temperature and solubility (TJP
and TDH, manuscript in preparation). The resulting poly-
peptide retained its sequence-speciﬁc DNA-binding activity.
We therefore examined its ability to crystallize in complex
with an oligonucleotide containing a p53 DNA-binding site
using the microbatch and vapour-diffusion protocols and three
different crystallization buffers. Crystals formed with both
protocols after 6 d incubation at 277 K in the COP cards.
Tabulating the results shows that vapour diffusion yielded
p53–DNA crystals with all three crystallization buffers,
whereas with the microbatch method p53–DNA crystals were
only obtained with two of the three crystallization buffers
(Fig. 2b). The p53 polypeptide–DNA complex also crystallized
using the hanging-drop vapour-diffusion method in 48-well
plates under the same crystallization conditions (TJP and
TDH, manuscript in preparation).
As a second protein that had not been previously
crystallized, we focused on A. thaliana Morpheus’ molecule 1
(MOM1), a protein that regulates chromatin structure and
gene expression without affecting DNA and histone methyl-
ation (Amedeo et al., 2000; Habu et al., 2006). An evolution-
arily and functionally conserved domain of MOM1 maps to a
region approximately between amino acids 1734 and 1815
(Caikovski et al., 2008). We expressed various MOM1 frag-
ments in E. coli and found by systematic deletion analysis that
a MOM1 polypeptide corresponding to residues 1699–1814 of
the full-length protein is soluble. This polypeptide was puriﬁed
to homogeneity and examined for crystallization at 277 K by
the microbatch, vapour-diffusion and free-interface diffusion
methods in COP cards, varying the concentration of the
precipitant from 0.2 to 0.4 M. The best results were achieved
using the vapour-diffusion protocol (Fig. 2c). This fragment
of MOM1 also crystallized using the hanging-drop vapour-
research papers
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Figure 2
Protein crystallization in COP cards. (a) Lysozyme and trypsin crystals formed in COP cards using the microbatch protocol. (b) Crystallization of human
p53–DNA complexes in COP cards using the microbatch and vapour-diffusion protocols and three precipitant solutions (Index Screen Nos. 87, 89 and
90). Each condition was performed in triplicate or quadriplicate (numbered 1–3 and 1–4, respectively) and the results are colour-coded as follows:
protein precipitate, grey; protein crystals, purple; clear solution, white. Examples of the crystals that were formed using each protocol are shown.( c)
Crystallization of A. thaliana MOM1 in COP cards using the microbatch, vapour-diffusion and free-interface diffusion protocols. Each condition was
performed in quadriplicate (numbered 1–4) using magnesium formate as the precipitant at the indicated concentrations. The results are colour-codeda s
described for the p53–DNA complexes in (b). For the free-interface diffusion protocol, both the protein (left half) and the precipitant (right half)
chambers were scored, since over time both chambers will contain both protein and precipitant. Examples of the crystals formed using each protocol are
shown. All images were acquired using the camera built into the microﬂuidics instrument. The width of the chambers is 750 mm. The detailed
compositions of the precipitant solutions are described in x2.diffusion method in 48-well plates under the same crystal-
lization conditions (data not shown).
3.4. Collection of X-ray diffraction data from crystals in COP
cards
The crystals that formed in the COP cards could easily be
harvested after opening the cards; these crystals could then
be cryopreserved, mounted on cryoloops and frozen, thus
allowing complete X-ray diffraction data sets to be collected.
When there is a need to examine many crystals, the ability to
collect X-ray diffraction data while the crystals are still in the
COP card could allow signiﬁcant savings in time and effort. A
robotic arm that is able to position crystallization multi-well
plates in front of an X-ray beam has already been described
(Jacquamet et al., 2004). By comparison to multi-well plates,
the geometry of the COP cards used in this study appears to be
well suited for in situ X-ray diffraction analysis.
To examine whether we could actually collect X-ray
diffraction data, COP cards containing p53–DNA, MOM1 and
lysozyme crystals were positioned by the robotic arm in the
path of the X-ray beam. The robotic arm was programmed to
rotate the card during data collection, allowing oscillation of
the crystal over a 1  range. For all crystals, we could observe
diffraction patterns that were of sufﬁcient quality to allow
indexing (Figs. 3a and 3b and data not shown). The p53–DNA
and MOM1 crystals exposed to X-rays in situ diffracted to a
somewhat lower resolution level than crystals that had been
harvested from the cards, cryopreserved, mounted on loops
and frozen. For example, cryopreserved p53–DNA crystals
diffracted to 3 A ˚ resolution, whereas the same crystals in COP
cards diffracted to about 4.5 A ˚ . We attribute this difference to
the temperature shift that occurred during data collection,
since the p53–DNA and MOM1 crystals formed at 277 K,
whereas the in situ data collection was performed at room
temperature. In contrast, the lysozyme crystals, which were
formed at room temperature, diffracted to a resolution of
1.5 A ˚ whenexposedtoX-raysthroughtheCOPcards(Fig.3b).
To evaluate the quality of the data collected from crystals in
COP cards, we obtained 45 consecutive X-ray diffraction
images, each over an oscillation range of 1 , from a lysozyme
crystal. The COP absorbed X-rays, but only over a narrow
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Figure 3
Collection of X-ray diffraction data sets from crystals in COP cards. (a) X-ray diffraction pattern of a p53–DNA crystal exposed to the X-ray beam while
still in the COP card. The oscillation range was 1 .( b) X-ray diffraction patterns of a lysozyme crystal exposed to the X-ray beam while still in the COP
card. Two regions of the diffraction image are shown, one encompassing a resolution range lower then 3.5 A ˚ (left) and the other a region from 1.9 to
1.6 A ˚ resolution (right). The oscillation range was 1 . Note that COP absorbs X-rays in the resolution range between 5.4 and 5.1 A ˚ .( c) Part of the
lysozyme electron-density map contoured at 1.9  for the 2Fo   Fc map (olive green) and at 3  for the Fo   Fc map (dark blue, positive values; orange,
negative value). The map shows residues Trp46, Val47 and Ile116 and part of the side chain of Trp126.resolution range from 5.4 to 5.1 A ˚ (Fig. 3b). In lower and
higher resolution ranges the COP did not compromise data
collection, as evidenced both by observing the X-ray diffrac-
tion images (Fig. 3b) and also from the statistics describing the
integration of the X-ray reﬂection intensities over the 45
frames of collected data (Table 1). Data in the resolution
range 40–1.5 A ˚ were used for reﬁnement using a previously
determined lysozyme structure as input (Sauter et al., 2001).
The reﬁned structure had excellent statistics (Table 1) and well
resolved electron-density maps (Fig. 3c), especially consid-
ering that data from only 45 frames were used for reﬁnement.
4. Discussion
The need to optimize the efﬁciency with which X-ray
diffraction-quality protein crystals are produced has led to the
development of methods for automating the setup of protein
crystallization reactions and for reducing the amount of pro-
tein required (Chayen & Saridakis, 2008). Most microﬂuidics
systems utilize silicone elastomers as the chip material and
have achieved exceptional economies in the amount of protein
consumed: in one system, 10 nl protein solution is required per
crystallization condition. However, silicone elastomers are
also highly permeable to water vapour and this limits their
utility to proteins that crystallize within a few days (Hansen &
Quake, 2003). Materials that are impermeable to water vapour
have also been explored in protein crystallography at a
miniaturized scale, but in general these systems require
signiﬁcant human intervention or are compatible with only
one method of protein crystallization, usually free-interface
diffusion (Ng et al., 2003, 2008). This is because materials that
are impermeable to water vapour, such as COPs, are rigid.
Unlike chips made of silicone elastomers, in which liquids can
be moved by deforming the chip itself, the movement of nano-
litre volumes of liquid in rigid chips is not a trivial task. The
system we used here solves the ‘pipetting’ problem by opening
holes at deﬁned positions to control the volume of liquid to be
dispensed and by spinning the cards to move the liquids by
centrifugal force. Once the problem of pipetting had been
addressed, COP-based microﬂuidic chips could easily be
adapted for protein crystallization using several well estab-
lished protocols, as demonstrated here.
COP cards may overcome some of the limitations inherent
in microﬂuidics chips made of silicon elastomers. The ﬁrst is
the issue of water-vapour permeability. In COP cards there is
very little water evaporation even after months of incubation
at room temperature. A second limitation of silicone elas-
tomer chips is that crystals cannot readily be isolated for X-ray
diffraction analysis. This means that new protein crystals
have to be obtained using traditional protein crystallization
methods. In some cases, it is not straightforward to translate
the conditions under which proteins crystallize by free-inter-
face diffusion in the microﬂuidics chip to conditions under
which they will crystallize by the traditional hanging-drop
vapour-diffusion method in multi-well plates. COP cards
overcome this limitation, because the volume of the chambers
(320 nl) allows even relatively large protein crystals to form;
these crystals can then be easily harvested from the COP cards
for the collection of X-ray diffraction data sets. Alternatively,
limited diffraction data can also be collected from the crystals
in situ, because COPs absorb X-rays only within a deﬁned
resolution range of about 5.4–5.1 A ˚ (Fig. 3a;N get al., 2008). In
exceptional cases, as illustrated here with the example of
lysozyme, entire X-ray diffraction data sets can be collected.
However, this was possible with lysozyme because sufﬁcient
data could be collected from just 45 images and because the
lysozyme crystals did not suffer extensive radiation damage,
even though the COP card was at room temperature during
data collection. In the case of the MOM1 and p53–DNA
crystals only about ten images could be collected per crystal.
COP-based microﬂuidics systems compare favourably with
automated pipetting systems that set up crystallization reac-
tions in multi-well plates (Chayen & Saridakis, 2008). In the
latter systems all pipetting steps are performed in an open
environment, which allows water to evaporate while the drops
are being set up, especially when the volume of these drops is
in the nanolitre range. In contrast, in microﬂuidics systems all
pipetting steps are performed in a closed environment, thus
eliminating the problem of water evaporation during setup.
Further, the COP cards described here can be stacked in
holders, so that their inlets adopt the same geometry as the
wells of 384-well plates. Thus, the initial loading of protein
samples and precipitant solutions in the COP cards can be
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Table 1
Data-collection and reﬁnement statistics for a lysozyme data set
comprised of 45 consecutive frames, each having an oscillation range
of 1 .
Values in parentheses are for the highest resolution shell.
Data collection
X-ray wavelength (A ˚ ) 0.97958
Space group P43212
Unit-cell parameters (A ˚ ) a = 77.1, b = 77.1, c = 37.2
Resolution (A ˚ ) 40–1.5 (1.59–1.5)
Observations 73037 (11316)
Unique reﬂections 18458 (2903)
Data coverage (%) 91.7 (91.5)
hI/ (I)i 12.5 (4.1)
Rmerge† (%) 6.8 (31.6)
Reﬁnement statistics
Resolution range (A ˚ ) 40–1.5
Reﬂections used [>0 (F)] 17529
Protein atoms 1001
Water molecules 110
R factor‡ (%) 21.6
Rfree§ (%) 23.8
R.m.s. deviations}
Bonds (A ˚ ) 0.006
Angles ( ) 1.264
Ramachandran plot
Most favoured (%) 85.8
Allowed (%) 14.2
Disallowed (%) 0.0
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ for the intensity (I)o fi
observations of reﬂection hkl.‡ R factor =
P
hkl jFobs   Fcalcj=
P
hkl jFobsj, where Fobs
and Fcalc are the observed and calculated structure factors, respectively. § Rfree is the R
factor calculated using 5% of the reﬂection data chosen randomly and omitted from the
start of reﬁnement. } R.m.s. deviations for bonds and angles are the respective root-
mean-square deviations from ideal values.performed with standard pipetting robots. A ﬁnal advantage
of the COP cards is the geometry of their chambers, which
allows easy visualization of their contents. Thus, protein
crystals can be easily identiﬁed, a task that is much harder to
accomplish with crystals formed in round hanging or sitting
drops. Based on our experience, we anticipate that COP-based
microﬂuidics will play an important role in protein crystal-
lization efforts in the near future.
We thank SpinX Technologies for access to their proprie-
tary microﬂuidics technology, solutions and methods and John
Halazonetis for help with reﬁnement of the lysozyme struc-
ture. Financial support was provided by a Swiss National
Science Foundation grant to TDH. Conﬂicts of interest: JLF is
a founding partner of NatX-ray, a company that aims to
develop robotics arms for positioning microwell plates and
cryoloops in front of X-ray beams.
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